Who Supplies Enoxaparin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Enoxaparin exports, with 223+ registered manufacturers shipping to buyers across 118+ countries — yet a handful of companies dominate the shipments. GLAND PHARMA LTD holds the largest share at 28.9% (export value: $60.5M). Close behind, GLAND PHARMA LIMITED (13.2%, $27.6M). BIOLOGICAL E. LIMITED (9.1%, $19.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Enoxaparin? Top Manufacturers & Their Buyers
Flow of Enoxaparin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Enoxaparin Supplier Network — Key Market Intelligence
The Enoxaparin export market from India is led by GLAND PHARMA LTD, which alone commands a 28.9% share, shipping $60.5M worth of product across 669 shipments. The second-largest exporter, GLAND PHARMA LIMITED, contributes $27.6M (13.2%) to the overall market. Combined, the top two suppliers alone account for 42.1% of all Enoxaparin exports, indicating a relatively concentrated supply base.
Across all 223 tracked manufacturers, the total Enoxaparin export value stands at $209.4M from 3.3K shipments. The market average shipment value is $63.3K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI USA LLC,, receiving $38.8M worth of product.
The combined buyer network spans 22 named purchasing companies, including FRESENIUS KABI USA LLC,, BOSTON ONCOLOGY ARABIA NA, EVERSANA, EVERSANA LIFE SCIENCE SERVICES LLC, STATE PHARMACEUTICALS CORPORATION and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GLAND PHARMA LTD
GLAND PHARMA LTD is the first-largest Enoxaparin exporter from India, with a market share of 28.9% and a total export value of $60.5M across 669 shipments. Their average shipment value of $90.5K is above the market average of $63.3K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 5 named buyers in our database. FRESENIUS KABI USA LLC, is the dominant customer, accounting for 64.1% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI USA LLC, — $38.8M across 429 shipments (64.1% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA NA — $9.3M across 102 shipments (15.3% of this supplier's total exports)
• EVERSANA — $5.7M across 63 shipments (9.4% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $4.8M across 53 shipments (7.9% of this supplier's total exports)
• STATE PHARMACEUTICALS CORPORATION — $2.0M across 22 shipments (3.3% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $90.5K is 43% above the market average of $63.3K, consistent with large-order contracts or value-added formulations.
2GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the second-largest Enoxaparin exporter from India, with a market share of 13.2% and a total export value of $27.6M across 495 shipments. Their average shipment value of $55.8K is below the market average of $63.3K, reflecting a high-volume, competitive pricing strategy.
GLAND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI USA LLC, — $11.8M across 211 shipments (42.6% of this supplier's total exports)
• BOSTON ONCOLOGY ARABIA NA — $8.7M across 157 shipments (31.6% of this supplier's total exports)
• EVERSANA EVERSANA — $3.6M across 65 shipments (13.1% of this supplier's total exports)
• STATE PHARMACEUTICALS CORPORATION — $2.0M across 36 shipments (7.2% of this supplier's total exports)
• EVERSANA — $1.5M across 27 shipments (5.5% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED operates with high shipment frequency (495 shipments) at a per-shipment value of $55.8K, indicating a broad distribution network with many smaller, regular orders.
3BIOLOGICAL E. LIMITED
BIOLOGICAL E. LIMITED is the third-largest Enoxaparin exporter from India, with a market share of 9.1% and a total export value of $19.0M across 226 shipments. Their average shipment value of $84.0K is above the market average of $63.3K, suggesting premium or bulk contract pricing.
BIOLOGICAL E. LIMITED serves 5 named buyers in our database. BE PHARMACEUTICALS INC is the dominant customer, accounting for 88.5% of this supplier's tracked business. Top customers include:
• BE PHARMACEUTICALS INC — $16.8M across 200 shipments (88.5% of this supplier's total exports)
• BE PHARMACEUTICALS INC — $785.4K across 9 shipments (4.1% of this supplier's total exports)
• CARITAS PHARMA S.A D — $668.6K across 8 shipments (3.5% of this supplier's total exports)
• FRESENIUS KABI CANADA LTD — $447.1K across 5 shipments (2.4% of this supplier's total exports)
• BE PHARMACEUTICALS INC — $280.5K across 3 shipments (1.5% of this supplier's total exports)
Key Insight: BIOLOGICAL E. LIMITED's per-shipment value of $84.0K is 33% above the market average of $63.3K, consistent with large-order contracts or value-added formulations.
4BRAWN LABORATORIES LIMITED
BRAWN LABORATORIES LIMITED is the fourth-largest Enoxaparin exporter from India, with a market share of 1.8% and a total export value of $3.8M across 72 shipments. Their average shipment value of $53.4K is below the market average of $63.3K, reflecting a high-volume, competitive pricing strategy.
BRAWN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PEOPLES BANK — $1.4M across 26 shipments (35.4% of this supplier's total exports)
• PEOPLES BANK — $1.3M across 25 shipments (34.9% of this supplier's total exports)
• AMBICA INTERNATIONAL — $637.4K across 12 shipments (16.6% of this supplier's total exports)
• NA — $373.0K across 7 shipments (9.7% of this supplier's total exports)
• BANCO POPULAR DOMINI — $131.6K across 2 shipments (3.4% of this supplier's total exports)
Key Insight: BRAWN LABORATORIES LIMITED operates with high shipment frequency (72 shipments) at a per-shipment value of $53.4K, indicating a broad distribution network with many smaller, regular orders.
5VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Enoxaparin exporter from India, with a market share of 0.7% and a total export value of $1.4M across 182 shipments. Their average shipment value of $7.7K is below the market average of $63.3K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• 2MG 2MG INC — $457.0K across 59 shipments (32.5% of this supplier's total exports)
• S T C — $345.7K across 45 shipments (24.6% of this supplier's total exports)
• PT M L — $268.2K across 35 shipments (19.1% of this supplier's total exports)
• T P D S L — $174.9K across 23 shipments (12.4% of this supplier's total exports)
• TO TADHAMON BANK — $160.5K across 21 shipments (11.4% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (182 shipments) at a per-shipment value of $7.7K, indicating a broad distribution network with many smaller, regular orders.
6EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the fifth-largest Enoxaparin exporter from India, with a market share of 0.7% and a total export value of $1.4M across 187 shipments. Their average shipment value of $7.3K is below the market average of $63.3K, reflecting a high-volume, competitive pricing strategy.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LAZOR PHARMACEUTICAL — $318.6K across 43 shipments (23.2% of this supplier's total exports)
• MACROPHARMA CORPORAT — $311.5K across 42 shipments (22.7% of this supplier's total exports)
• AUGUSTA LTD — $292.9K across 40 shipments (21.3% of this supplier's total exports)
• KHETAN COMPANY LIMIT — $267.9K across 36 shipments (19.5% of this supplier's total exports)
• SUED & FARGESA S.R.L — $181.6K across 25 shipments (13.2% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (187 shipments) at a per-shipment value of $7.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Enoxaparin Flows
Once Enoxaparin leaves the manufacturing plants of companies like GLAND PHARMA LTD and GLAND PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $209.4M. United States absorbs the largest share at 49.0% ($102.7M), followed by Saudi Arabia (22.0%) and Sri Lanka (3.8%).
In United States — the top destination — named importers include FRESENIUS KABI USA, LLC, BE PHARMACEUTICALS INC, FRESENIUS KABI USA LLC. In Saudi Arabia, key buyers are BOSTON ONCOLOGY ARABIA, BOSTON ONCOLOGY ARABIA NA.
This geographic spread reflects Enoxaparin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Enoxaparin Go? Top Importing Countries & Their Buyers
Trade flow of Enoxaparin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Enoxaparin imports from India, with a total trade value of $102.7M across 744 shipments — representing a 49.0% share of all Enoxaparin exports. The average shipment value of $138.0K is above the global average of $63.3K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Enoxaparin importers in United States: FRESENIUS KABI USA, LLC is the largest buyer, accounting for 47.3% ($48.6M) of this market's total imports.
• FRESENIUS KABI USA, LLC — $48.6M (47.3% of United States's total)
• BE PHARMACEUTICALS INC — $20.9M (20.3% of United States's total)
• FRESENIUS KABI USA LLC — $12.0M (11.7% of United States's total)
Key Insight: United States's per-shipment average of $138.0K (118% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Enoxaparin imports from India.
2Saudi Arabia
Saudi Arabia ranks as the second-largest destination for Enoxaparin imports from India, with a total trade value of $46.1M across 259 shipments — representing a 22.0% share of all Enoxaparin exports. The average shipment value of $178.1K is above the global average of $63.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Enoxaparin importers in Saudi Arabia: BOSTON ONCOLOGY ARABIA is the largest buyer, accounting for 96.6% ($44.5M) of this market's total imports.
• BOSTON ONCOLOGY ARABIA — $44.5M (96.6% of Saudi Arabia's total)
• BOSTON ONCOLOGY ARABIA NA — $1.2M (2.7% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $178.1K (181% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Enoxaparin imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Enoxaparin imports from India, with a total trade value of $7.9M across 11 shipments — representing a 3.8% share of all Enoxaparin exports. The average shipment value of $714.9K is above the global average of $63.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Enoxaparin importers in Sri Lanka: STATE PHARMACEUTICALS CORPORATION is the largest buyer, accounting for 56.0% ($4.4M) of this market's total imports.
• STATE PHARMACEUTICALS CORPORATION — $4.4M (56.0% of Sri Lanka's total)
• PEOPLE'S BANK — $1.3M (17.1% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $714.9K (1030% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Enoxaparin imports from India.
4Canada
Canada ranks as the fourth-largest destination for Enoxaparin imports from India, with a total trade value of $5.2M across 87 shipments — representing a 2.5% share of all Enoxaparin exports. The average shipment value of $59.8K is below the global average of $63.3K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Enoxaparin importers in Canada: FRESENIUS KABI CANADA LTD is the largest buyer, accounting for 90.7% ($4.7M) of this market's total imports.
• FRESENIUS KABI CANADA LTD — $4.7M (90.7% of Canada's total)
Key Insight: Canada receives frequent, smaller shipments of Enoxaparin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Canada is a key market for Enoxaparin imports from India.
5Dominican Republic
Dominican Republic ranks as the fifth-largest destination for Enoxaparin imports from India, with a total trade value of $3.4M across 52 shipments — representing a 1.6% share of all Enoxaparin exports. The average shipment value of $66.3K is above the global average of $63.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Enoxaparin importers in Dominican Republic: PHARMACEUTICAL TECHNOLOGY is the largest buyer, accounting for 65.4% ($2.3M) of this market's total imports.
• PHARMACEUTICAL TECHNOLOGY — $2.3M (65.4% of Dominican Republic's total)
Key Insight: Dominican Republic's per-shipment average of $66.3K (5% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Dominican Republic is a key market for Enoxaparin imports from India.
People Also Ask — Enoxaparin Supplier & Trade Network
Who are the top suppliers of Enoxaparin from India?+
Which companies buy Enoxaparin from Indian manufacturers?+
Where does Enoxaparin exported from India go?+
What is the market share of the top Enoxaparin supplier from India?+
What is the average shipment value for Enoxaparin exports from India?+
Is Enoxaparin manufactured in India and exported globally?+
Which country imports the most Enoxaparin from India?+
Who are the buyers of Enoxaparin in Saudi Arabia?+
How concentrated is the Enoxaparin supplier market in India?+
How do I find verified buyers for Enoxaparin in specific countries?+
Enoxaparin Trade Network — Key Takeaways
- 1GLAND PHARMA LTD is India's dominant Enoxaparin exporter with a 28.9% market share and $60.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 223 suppliers collectively account for 54.3% of all tracked Enoxaparin exports, with a combined trade value of $209.4M.
- 3United States is the largest destination market, absorbing 49.0% of India's Enoxaparin exports ($102.7M). Saudi Arabia (22.0%) and Sri Lanka (3.8%) follow.
- 4With 3.3K total shipments averaging $63.3K each, the Enoxaparin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI USA LLC,, BOSTON ONCOLOGY ARABIA NA, FRESENIUS KABI USA LLC,, BOSTON ONCOLOGY ARABIA NA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 118 countries
Network value: $209.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Enoxaparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Enoxaparin.
- 2.Flow Mapping: 223 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,309 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 118 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,309 Verified Shipments
223 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists